Abstract
Two new ring-size-varying analogues (2 and 3) of ipomoeassin F were synthesized and evaluated. Improved cytotoxicity (IC50: from 1.8 nM) and in vitro protein translocation inhibition (IC50: 35 nM) derived from ring expansion imply that the binding pocket of Sec61α (isoform 1) can accommodate further structural modifications, likely in the fatty acid portion. Streamlined preparation of the key diol intermediate 5 enabled gram-scale production, allowing us to establish that ipomoeassin F is biologically active in vivo (MTD: μ3 mg/kg).
Original language | English |
---|---|
Journal | Journal of Organic Chemistry |
Volume | 85 |
Issue number | 24 |
Pages (from-to) | 16226-16235 |
Number of pages | 10 |
ISSN | 0022-3263 |
DOIs | |
Publication status | Published - 18 Dec 2020 |
Externally published | Yes |
MoE publication type | A1 Journal article-refereed |
Bibliographical note
Funding Information:This work was supported by Grant No. 2R15GM116032-02A1 from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) and a Ball State University (BSU) Provost Startup Award (to W.Q.S.), together with Wellcome Trust Investigator Award in Science ref no. 204957/Z/16/Z (to S.H.). L.E.A. is the recipient of BSU honors college research grants from 01/2020–12/2020.
Publisher Copyright:
© 2020 American Chemical Society.